Not exact matches
Recently, teaming up with co-investigator Associate Professor Dr. Rolf A. Brekken, they looked into its possible involvement in Pancreatic Ductal
Adenocarcinoma (PDA), the most common form
of pancreatic cancer, in a mouse
model with an early onset aggressive form
of tumor development.
Stomnes, a postdoctoral researcher working with Philip Greenberg, M.D., and Sunil Hingorani, M.D., Ph.D., at the Fred Hutchinson Cancer Center at the University
of Washington, has developed a mouse
model of pancreatic ductal
adenocarcinoma that is particularly good for studying this disease.
Berkeley Lab researchers have developed the first clinically - relevant mouse
model of human breast cancer to successfully express functional estrogen receptor positive
adenocarcinomas.
This approach has led to the finding that activated fibroblasts in the tumor stroma mediate immune suppression in several mouse
models of cancer, including the autochthonous
model of pancreatic ductal
adenocarcinoma of the Tuveson lab.